✦ LIBER ✦

658 PROGNOSTIC FACTORS FOR RECURRENCE AND PROGRESSION IN T1G3 BLADDER CANCER TREATED WITH BCG: CIS IN THE PROSTATIC URETHRA AND GENDER

✍ Scribed by J. Palou; J.M. Gaya; R. Sylvester; Faba O. Rodríguez; J. Huguet; R. Parada; M. Pascual; F. Algaba; H. Villavicencio

Book ID: 119619983
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 506 KB
Volume: 8
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(09)60653-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Female Gender and Carcinoma In Situ in t

Female Gender and Carcinoma In Situ in the Prostatic Urethra Are Prognostic Factors for Recurrence, Progression, and Disease-Specific Mortality in T1G3 Bladder Cancer Patients Treated With Bacillus Calmette-Guérin

✍ Joan Palou; Richard J. Sylvester; Oscar Rodríguez Faba; Rubén Parada; Juan A. Pe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 427 KB

1353 LOCATION OF TUMORS IN EARLY AND LAT

1353 LOCATION OF TUMORS IN EARLY AND LATE RECURRENCES IN PATIENTS WITH T1G3 BLADDER CANCER TREATED WITH OR WITHOUT BCG: IS THERE ANY DIFFERENCE?

✍ Urdaneta, Guillermo; Palou, Juan; Serrano, Miriam; Parada, Rubén; Rodríguez, Osc 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 84 KB

TIME AND GRADE OF THE FIRST RECURRENCE A

TIME AND GRADE OF THE FIRST RECURRENCE AFTER BCG TREATMENT IN PATIENTS WITH PRIMARY PT1G3 BLADDER CANCER ARE USEFUL RISK FACTORS TO DETERMINE THE RISK OF PROGRESSION

✍ Lampe, Menuhin; Palou, Juan; Sabaté, Sergi; Huguet, Jordi; Sagristà, Rosa; Rodrí 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 54 KB

1042 LOCATION OF THE TUMOURS IN EARLY AN

1042 LOCATION OF THE TUMOURS IN EARLY AND LATE RECURRENCES IN PATIENTS WITH T1G3 BLADDER TUMOURS TREATED WITH OR WITHOUT BCG: IS THERE ANY DIFFERENCE?

✍ Urdaneta, G.; Palou, J.; Serrano, M.; Parada, R.; Rodríguez, O.; Gausa, L.; Bred 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 77 KB

817 MYOPODIN METHYLATION IS A PROGNOSTIC

817 MYOPODIN METHYLATION IS A PROGNOSTIC AND PREDICTIVE MARKER TO THE BACILLUS OF CALMETTE-GUERIN (BCG) RESPONSE IN PATIENTS WITH T1G3 BLADDER CANCER

✍ M. Álvarez Múgica; V. Cebrían; J.M. Fernández Gómez; F. Fresno; S. Escaf Barmada 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Prognostic Factors and Risk Groups in T1

Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients

✍ Gontero, Paolo; Sylvester, Richard; Pisano, Francesca; Joniau, Steven; Vander Ee 📂 Article 📅 2015 🏛 Elsevier Science 🌐 English ⚖ 470 KB